VITRAKVI FDA approval date

The FDA approved VITRAKVI on 26 Nov 2018.

FDA approval date
26 Nov 2018

Drug identity has not yet been verified against registry records

Also recorded as LAROTRECTINIB SULFATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-11-26DayVITRAKVIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA210861", "applicant_as_listed_by_fda": "BAYER HLTHCARE", "brand_names": ["VITRAKVI"], "active_ingredients": ["LAROTRECTINIB SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20181126", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026